Connolly Mark P, Kotsopoulos Nikolaos, Postma Maarten J, Bhatt Aomesh
Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Global Market Access Solutions, St-Prex, Switzerland.
Global Market Access Solutions, St-Prex, Switzerland.
Value Health. 2017 Feb;20(2):273-277. doi: 10.1016/j.jval.2016.11.018.
Governments have an enormous economic and political stake in the health of their populations. Population health is not only fundamental to economic growth but also affects short-term and long-term government expenditure on health care, disability, and other social programs and influences direct and indirect tax receipts. Fiscal transfers between citizen and state are mostly ignored in conventional welfare economics analyses based on the hypothesis that there are no winners or losers through transference of wealth. However, from the government perspective, this position is flawed, as disability costs and lost taxes attributed to poor health and reduced productive output represent real costs that pose budgetary and growth implications. To address the value of health and health care investments for government, we have developed a fiscal health analytic framework that captures how changes in morbidity and mortality influence tax revenue and transfer costs (e.g., disability, allowances, ongoing health costs). The framework can be used to evaluate the marginal impact of discrete investments or a mix of interventions in health care to inform governmental budgetary consequences. In this context, the framework can be considered as a fiscal budget impact and/or cost-benefit analysis model that accounts for how morbidity and mortality linked to specific programs represent both ongoing costs and tax revenue for government. Mathematical models identical to those used in cost-effectiveness analyses can be employed in fiscal analysis to reflect how disease progression influences public accounts (e.g., tax revenue and transfers).
政府在其民众的健康方面有着巨大的经济和政治利益。民众健康不仅是经济增长的基础,还会影响政府在医疗保健、残疾及其他社会项目上的短期和长期支出,并对直接和间接税收收入产生影响。在基于财富转移不存在赢家或输家这一假设的传统福利经济学分析中,公民与国家之间的财政转移大多被忽视。然而,从政府的角度来看,这种观点是有缺陷的,因为因健康状况不佳和生产产出下降而产生的残疾成本和税收损失代表了实际成本,对预算和增长产生影响。为了评估健康及医疗保健投资对政府的价值,我们开发了一个财政健康分析框架,该框架能够捕捉发病率和死亡率的变化如何影响税收收入和转移成本(如残疾、津贴、持续的医疗成本)。该框架可用于评估医疗保健中离散投资或一系列干预措施的边际影响,以告知政府预算后果。在此背景下,该框架可被视为一种财政预算影响和/或成本效益分析模型,该模型考虑了与特定项目相关的发病率和死亡率如何既代表政府的持续成本又代表税收收入。财政分析中可采用与成本效益分析中使用的相同数学模型,以反映疾病进展如何影响公共账户(如税收收入和转移支付)。